| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |